Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.20.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2018 $ 17,147 $ 55 $ 114,618 $ (97,377) $ (149)
Beginning balance, Shares at Dec. 31, 2018   10,864,722      
Exercise of stock options 219 $ 1 218    
Exercise of stock options, Shares   177,408      
Issuance of common stock upon secondary offering, net of costs 10,554 $ 1 10,553    
Issuance of common stock upon secondary offering net of costs, Shares   250,000      
Issuance of common stock from RSUs vested, Shares   28,790      
Stock-based compensation 754   754    
Other comprehensive income (loss) (13)       (13)
Net income (loss) (362)     (362)  
Ending balance at Mar. 31, 2019 28,299 $ 57 126,143 (97,739) (162)
Ending balance, Shares at Mar. 31, 2019   11,320,920      
Beginning balance at Dec. 31, 2018 $ 17,147 $ 55 114,618 (97,377) (149)
Beginning balance, Shares at Dec. 31, 2018   10,864,722      
Repurchase of common stock, Shares 0        
Net income (loss) $ 25        
Ending balance at Jun. 30, 2019 30,448 $ 57 127,870 (97,352) (127)
Ending balance, Shares at Jun. 30, 2019   11,476,685      
Beginning balance at Mar. 31, 2019 28,299 $ 57 126,143 (97,739) (162)
Beginning balance, Shares at Mar. 31, 2019   11,320,920      
Exercise of stock options 129   129    
Exercise of stock options, Shares   65,960      
Issuance of common stock in connection with exercise of warrants 51   51    
Issuance of common stock in connection with exercise of warrants, Shares   12,225      
Issuance of common stock from RSUs vested, Shares   24,072      
Issuance of common stock from ESPP purchase 642   642    
Issuance of common stock from ESPP purchase, Shares   53,508      
Stock-based compensation 905   905    
Other comprehensive income (loss) 35       35
Net income (loss) 387     387  
Ending balance at Jun. 30, 2019 30,448 $ 57 127,870 (97,352) (127)
Ending balance, Shares at Jun. 30, 2019   11,476,685      
Beginning balance at Dec. 31, 2019 27,251 $ 57 122,907 (95,579) (134)
Beginning balance, Shares at Dec. 31, 2019   11,314,150      
Exercise of stock options 57   57    
Exercise of stock options, Shares   17,543      
Issuance of common stock in connection with exercise of warrants, Shares   46,939      
Issuance of common stock from RSUs vested, Shares   20,297      
Stock-based compensation 887   887    
Other comprehensive income (loss) (227)       (227)
Net income (loss) 13     13  
Ending balance at Mar. 31, 2020 27,981 $ 57 123,851 (95,566) (361)
Ending balance, Shares at Mar. 31, 2020   11,398,929      
Beginning balance at Dec. 31, 2019 27,251 $ 57 122,907 (95,579) (134)
Beginning balance, Shares at Dec. 31, 2019   11,314,150      
Repurchase of common stock $ (1,600)        
Repurchase of common stock, Shares (74,520)        
Net income (loss) $ 879        
Ending balance at Jun. 30, 2020 28,868 $ 57 123,848 (94,700) (337)
Ending balance, Shares at Jun. 30, 2020   11,395,156      
Beginning balance at Mar. 31, 2020 27,981 $ 57 123,851 (95,566) (361)
Beginning balance, Shares at Mar. 31, 2020   11,398,929      
Exercise of stock options 41   41    
Exercise of stock options, Shares   26,562      
Issuance of common stock from RSUs vested, Shares   22,754      
Issuance of common stock from ESPP purchase 408   408    
Issuance of common stock from ESPP purchase, Shares   21,431      
Repurchase of common stock (1,615)   (1,615)    
Repurchase of common stock, Shares   (74,520)      
Stock-based compensation 1,163   1,163    
Other comprehensive income (loss) 24       24
Net income (loss) 866     866  
Ending balance at Jun. 30, 2020 $ 28,868 $ 57 $ 123,848 $ (94,700) $ (337)
Ending balance, Shares at Jun. 30, 2020   11,395,156